Dual roles of TGFβ in lupus nephritis.

被引：0
|
作者：
Singh, RR [1 ]
Lienesch, DW [1 ]
Saxena, V [1 ]
Adams, DE [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [31] The antiphospholipid-related component of lupus nephritis.
    Daugas, E
    Huong, DLT
    Nochy, D
    Beaufils, H
    Piette, JC
    Hill, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S365 - S365
  • [32] The prevalences and clinical characteristics of ANCAs in lupus nephritis.
    Chin, HJ
    Ahn, C
    Lim, CS
    Park, IS
    Han, JS
    Kim, S
    Lee, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0400 - A0400
  • [33] Urinary TWEAK is a novel biomarker for lupus nephritis.
    Schwartz, Noa
    Su, Lihe
    Burkly, Linda C.
    Gao, Hua-Xin
    Aranow, Cynthia
    Mackay, Meggan
    Michaelson, Jennifer S.
    Rovin, Brad
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S456 - S456
  • [34] The effective use of Mycophenolate mofetil in the treatment of lupus nephritis.
    Kingdon, EJ
    Psimenou, E
    Sweny, P
    Burns, A
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2563 - 2563
  • [35] Current therapy of lupus nephritis.: Which is the best option?
    Silva-Fernandez, L.
    Andreu-Sanchez, J. L.
    Ginzler, E. A.
    REVISTA CLINICA ESPANOLA, 2008, 208 (03): : 138 - 141
  • [36] B lymphocytes and plasma cells in human lupus nephritis.
    Guttikonda, Riteesha
    Chang, Anthony
    Liu, Ni
    Henderson, Scott G.
    Clark, Marcus R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4029 - 4029
  • [37] Disease Specific Quality of Life in Patients with Lupus Nephritis.
    Mok, Chi Chiu
    Toloza, Sergio
    Goker, Berna
    Clarke, Ann E.
    Navarra, S.
    Wallace, Daniel J.
    Weisman, Michael H.
    Jolly, Meenakshi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S736 - S737
  • [38] Further description of early clinically silent lupus nephritis.
    Zaboleta-Lanz, Mercedes
    Munoz, Luis
    Tapanes, Francisco
    Daboin, Iraida
    Pinto, Jose
    Vargas-Arenas, Rafael
    Barrios, Yadira
    Bianco, Nicolas
    CLINICAL IMMUNOLOGY, 2006, 119 : S69 - S69
  • [39] Pharmacogenetic determinant of cyclophosphamide therapy in patients with lupus nephritis.
    Arefayene, M
    Desta, Z
    Takada, K
    Yarboro, C
    Carrero, H
    Illei, G
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P97 - P97
  • [40] Increase of plasma and urine MIF in SLE and lupus nephritis.
    Seo, YI
    Park, MK
    Cho, ML
    Hong, JH
    Kim, HL
    Park, KS
    Yoon, CH
    Kim, WU
    Hong, YS
    Lee, SH
    Park, SH
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S196 - S196
12345